Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASF1057 in Seborrhoeic Dermatitis
NCT00565279Phase 3Completed
- Sponsor
- Astion Pharma
- Start
- Dec 2007
- Primary completion
- May 2008
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of ASF-1057 in seborrheic dermatitis (SD), sponsored by Astion Pharma. Started Dec 2007; status: completed.
02
Drugs
ASF-1057
03
Conditions
seborrheic dermatitis (SD)
Beyond the preview
Go deeper on NCT00565279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00565279.